Emergent BioSolutions to Release Second Quarter 2021 Financial Results and Conduct a Conference Call on July 29, 2021
Emergent BioSolutions Inc. (NYSE: EBS) will hold a conference call on July 29, 2021, at 5:00 PM ET to discuss its Q2 2021 financial results and provide revenue guidance for Q3 2021 and the full year.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions Inc. (NYSE: EBS) will hold a conference call on July 29, 2021, at 5:00 PM ET to discuss its Q2 2021 financial results and provide revenue guidance for Q3 2021 and the full year. Investors can join via phone or webcast, with access details provided. Emergent aims to enhance life through its specialty products and services dedicated to public health, aspiring to protect or enhance one billion lives by 2030. For more details, visit their official website.
Positive
- Scheduled conference call to discuss financial results and guidance indicates proactive investor engagement.
Negative
- None.
Details
News Market Reaction – EBS
The recorded move for EBS in the trading session of this news was +3.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial results for the second quarter of 2021, recent business developments, revenue guidance for the third quarter of 2021, and financial outlook for full year 2021.
This conference call can be accessed live by telephone or by webcast:
| Teleconference Information: Dial in number – toll-free: (855) 766-6521 Dial in number – toll: (262) 912-6157 Conference ID: 1089625 Webcast Information: Visit https://edge.media-server.com/mmc/p/yzfzc7j7 for the live webcast. |
A replay of the call can be accessed from the Emergent website.
About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
burrowsr@ebsi.com
Media Contact:
Matt Hartwig
Director, Media Relations
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.